Global Pricing & Access Lead, Rare Neurology

Alexion Pharmaceuticals Inc Company; Barcelona; Híbrido; EUR 120 000 - 160 000; Tempo integral

Resumo da oferta

Alexion, AstraZeneca Rare Disease, seeks a Director of Global Value Access and Pricing (GVAP) to lead cross-country NMOSD access strategies from Barcelona. You will shape global value propositions, guide evidence plans, and drive pricing decisions across EU markets.

This role demands deep HTA experience and strong collaboration with HEOR, Medical, and Commercial teams. You will shape country-specific access narratives, support P&R submissions, and oversee lifecycle management with a focus on

Qualificações

• Demonstrated leadership in rare-disease market access and global pricing.
• Experience building evidence strategies with HTA bodies and payers.
• Strong cross-functional collaboration across HEOR, Medical, and Commercial.

Responsabilidades

• Lead global market access and pricing strategies for NMOSD and Neurology indications.
• Develop value propositions and pricing tools to support P&R submissions.
• Coordinate evidence generation plans and RWE to reduce payer uncertainty and improve patient access.
• Represent GVAP in cross-functional and country-facing discussions and governance processes.

Conhecimentos

Strategic leadership

Cross-functional collaboration

HTA knowledge

Global market access

Neurology expertise

Payer negotiations

RWE planning

Formação académica

PhD/PharmD/BiomedicalSciences/ economics

Descrição da oferta de emprego

Location: Barcelona - Spain (3 days working from the office and 2 days working from home)

AtAlexion, AstraZeneca Rare Disease, this role offers the opportunity to shape access for transformative medicines in areas of high unmet need and make a meaningful impact for patients living withrare neurological diseases. You will operate in a highly visible, strategic position with broad cross-functional exposure, leading portfolio-level market access, pricing, and reimbursement strategy across key markets, with a particular focus on theNMOSDindication. This is an opportunity for an experienced market access leader to influence critical launch and lifecycle decisions, navigate complex payer environments, and play a central role in advancing our ambition withinNeurology.

What you’ll will do:

Join a highly valued, strategic team that is fundamental to realizing the potential of our life-changing medicines. Through our work, AstraZenecais able toensure that appropriate access is provided to our transformative therapies.

Alexion, AstraZeneca Rare Disease’sGlobal Value Access and Pricing (GVAP) team is seeking a qualifiedDirectorto join a dynamic and growing team, with responsibility forNeurologyindications, including near-term new product launches and label expansions.

As a key member of theGVAPteam, you will help shape and execute global value, access, and pricing strategies across theNeurology portfolioin selected key EU markets, with particular strategicfocus on theNMOSD indicationand its lifecycle management

This is a strategic role that leverages your understanding and application of global healthcare and health technology assessment (HTA) systems, competitive insights, and clinical knowledge to shape market access, pricing, and reimbursement success for critical product launches and indications.

The ideal candidate for this role will have deep expertise in global payer,HTA, and reimbursement ecosystems, with a strong track record of driving market access, pricing, and reimbursement success withinrare diseases and Neurology.

You will be responsible for:

Value

• Lead and drive cross-functional development of a clear, differentiated value proposition forNMOSD, while influencing without authority and navigating complex organizational systems.
• Collaborate with cross-functional teams to ensure that evidence generation plans and real-world evidence (RWE) are incorporated effectively to deliver a comprehensive value proposition, reduce uncertainty for payers, and optimize patient access. This includes securing timely country input on endpoints and evidence generation plans in priority target countries.
• Provide support to theGMMA Commercialteam to advanceNMOSD lifecycle management (LCM)through governance milestones focused on market access potential, evidence, andtarget product profile (TPP)requirements.

Access

• Leaddevelopmentofglobal market access and pricing strategies-activitiesandsupport implementationin close partnership with country access representativesofassigned countries
• Lead the assessment of pricing and reimbursement (P&R) risks and opportunities, and the implementation of corresponding mitigation actions specific toNeurology.
• Create and roll out strategic value, access, and pricing communication tools and materials forNMOSDto support localP&Rsubmissions and negotiations, such as pricing frameworks, negotiation strategies, and toolkits, in alignment with the enterprise-wide launch framework.
• Lead the update of the global reimbursement dossier forNMOSDand the overall cross-functional market access readiness plans forNeurology, in close collaboration with key countries and support functions (HEOR, Medical, and Commercial).
• Represent theGVAPperspective and strategy across various cross-functional teams, including theGlobal Value Sub-TeamandGlobal Launch Team, and provide updates and guidance to local teams as needed.
• Own the monthlyNeurologypayer working group to share the latest evidence and drive best practice sharing across countries.
• Understand and incorporate thepatientperspective on thedisease, andrecommend strategies that support thepatientvoice in key payer negotiations.

Pricing

• Support the development oftheNeurologypricing strategy.
• Conduct payer and value assessments to identify key market-specific P&R drivers and barriers, develop differentiated value propositions, and inform evidence generation plans, regulatory strategy, and development decisions.
• For the top EU Neurology markets, lead and co-create market-level P&R strategies and support P&R submissions and negotiations to drive positive outcomes.
• Review P&R cases submitted bymarkets, andsupport markets in maintaining value while unlocking local accessworking in close partnership with country access representatives and /or access International shared marketsGVAPteam for relevant countries.
• Offer critical strategic input to inform access and pricing assumptions, enabling accurate, market-driven LTP assumptions.
• Communicate effectively with GMMA senior leadership and other key stakeholders, particularly in relation toNeurology launches and NMOSD LCM P&R strategy.

You will need to have:

• Demonstratedleadership andtheability to take initiative and consistently deliver high-quality workin the context of rarediseases evidence, where there is greateruncertainty andcompetiiton.
• The abilitytocommunicate effectivelyand translatescience into compellingpayer value story benefitsforAlexionleadership and other identified stakeholders,including close collaborationwithlocal market access colleagues and the Commercial Launch Excellence function.
• Experiencedevelopingevidence-based innovative value solutions,for examplethrough working with local payers intheEU or commercial customers in the US.
• A relevantgraduate degree, such as aPhD, PharmD,BiomedicalSciences, business, or economicsqualification.
• Highly specialized rare diseaseand/or Neurologymarket access experience.
• More than 6 years of relevant drug development and/or commercialization experience within the pharmaceutical/medical industry.
• Knowledge of the needs and expectations of national and regional payers, insurers, and commercial customers in our strategic markets.Knowledge and experience in keycost-effectivenessmarkets, such as theUK, Canada andtheNordics,is preferred.
• The duties of this role are generally conducted in an office environment. As is typical of an office-based role, employees must be able, with or without accommodation,touse a computer; engage in communications via phone, video, and electronic messaging; engage in problem-solving and non-linear thought, analysis, and dialogue; collaborate with others; maintain general availability during standard business hours.

Date Posted

20-oct-2026

Closing Date

03-nov-2026

Alexion is proud to be an Equal Employment Opportunity and Aff-irmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex, sexual orientation, age, ancestry, national origin, ethnicity, citizenship status, marital status,pregnancy, (including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin aninteractive dialogue with Alexion regarding an accommodation, please contact [e-mail]. Alexion participates in E-Verify.